Brainstorm Cell Therapeutics Inc (BCLI) USD0.00005

Sell:$0.58Buy:$0.58Price unchangedNo change

Prices delayed by at least 15 minutes
Sell:$0.58
Buy:$0.58
Change:Price unchangedNo change
Deal now
Prices delayed by at least 15 minutes
Sell:$0.58
Buy:$0.58
Change:Price unchangedNo change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease; progressive multiple sclerosis (PMS); Alzheimer’s disease (AD); and other neurodegenerative diseases. Its NurOwn, a cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived MSCs to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. It has completed a Phase III pivotal trial in ALS (NCT03280056); this trial investigated the safety and efficacy of repeat-administration of autologous MSC-NTF cells. The Company's wholly owned subsidiary, Brainstorm Cell Therapeutics Ltd. holds exclusive rights to commercialize NurOwn technology.

Key people

Jacob A. Frenkel
Independent Chairman of the Board
Chaim Lebovits
President, Chief Executive Officer
Alla Patlis
Interim Chief Financial Officer, Controller
Hartoun Hartounian
Executive Vice President, Chief Operating Officer
Uri Yablonka
Director, Executive Vice President, Chief Business Officer, Secretary
Ibrahim B. Dagher
Executive Vice President, Chief Medical Officer
Irit Arbel
Independent Vice Chairman of the Board
Stacy R. Lindborg
Director
Menghisteab Bairu
Independent Director
Nir Naor
Independent Director
Anthony John Polverino
Independent Director
Click to see more

Key facts

  • Shares in issue
    11.04m
  • EPIC
    BCLI
  • ISIN
    US10501E3009
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $5.96m
  • Employees
    27
  • Exchange
    Over The Counter
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.